title: Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts.
abstract: Scirrhous gastric cancer cells proliferate rapidly with fibrosis, when the cancer cells invade into the submucosa of the stomach. To investigate the mechanisms responsible for the rapid proliferation, the growth interaction between gastric cancer cells and fibroblasts was examined. Human gastric cancer cell lines established from scirrhous carcinoma or well-differentiated adenocarcinoma were used. Human fibroblast cell lines were obtained from various organs. The growth interaction between gastric cancer cells and fibroblasts was examined by calculating the number of cancer cells or by measuring [3H]thymidine incorporation of cancer cells. Gastric fibroblasts specifically stimulated the growth of scirrhous gastric cancer cells, but not that of well-differentiated adenocarcinoma cells. The growth factor(s) produced from gastric fibroblasts were then partially purified and characterised. The growth-promoting factor(s) had apparent molecular weights of 10000 dalton and was sensitive both to heat and proteinase treatment. No inhibition for the factor(s) was achieved with defined anti-growth factor antibodies. In this study, differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts were shown. Rapid proliferation of scirrhous gastric carcinoma should be partly controlled by orthotopic fibroblasts. The growth factor(s) from gastric fibroblasts, which was distinct from various defined growth factors such as epidermal growth factor (EGF), basic fibroblast growth factor (b-FGF), transforming growth factor-alpha (TGF-alpha), keratinocyte growth factor (KGF), vascular endothelial growth factor (VEGF), insulin-like growth factor I (IGF-I), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF) and transforming growth factor beta 1 (TGF-beta 1) may play an important role in the progression of scirrhous gastric cancer cells.
authors.affiliation: First Department of Surgery, Osaka City University Medical School, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yashiro
authors.forename: Y S
authors.initials: YS
authors.lastname: Chung
authors.forename: T
authors.initials: T
authors.lastname: Kubo
authors.forename: F
authors.initials: F
authors.lastname: Hato
authors.forename: M
authors.initials: M
authors.lastname: Sowa
mesh_terms: D002293:Adenocarcinoma, Scirrhous / Q000473:pathology* / Q000556:secondary; D002455:Cell Division / Q000187:drug effects; D016895:Culture Media, Serum-Free / Q000737:chemistry / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000378:metabolism / Q000502:physiology*; D006133:Growth Substances / Q000302:isolation & purification / Q000502:physiology*; D006801:Humans; D009361:Neoplasm Invasiveness; D013270:Stomach / Q000473:pathology; D013274:Stomach Neoplasms / Q000473:pathology*; D014407:Tumor Cells, Cultured
chemical_list: D016895:Culture Media, Serum-Free; D006133:Growth Substances